Organon (OGN) reported Q4 adjusted earnings Thursday of $0.90 per diluted share, up from $0.88 a year earlier.

Analysts polled by FactSet expected $0.87.

Revenue for the quarter ended Dec. 31 was $1.59 billion, compared with $1.60 billion a year earlier.

Analysts surveyed by FactSet expected $1.59 billion.

For 2025, Organon said it expects revenue in the range of $6.13 billion to $6.33 billion.

Analysts polled by FactSet expect $6.43 billion.

Organon shares were up over 2% in recent Thursday premarket activity.